TCGA-B6-A0X7-01A-11R-A10J-07
— · A
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- —
- cancer_type_detailed
- —
- subtype
- A
- subtype
- A
- overall_survival_months
- 59
GSVA pathway preview (50 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Top 10 elevated
- UV_RESPONSE_DN+0.190
- ANGIOGENESIS+0.140
- TGF_BETA_SIGNALING+0.130
- MYOGENESIS+0.090
- NOTCH_SIGNALING+0.090
- EPITHELIAL_MESENCHYMAL_TRANSITION+0.080
- PANCREAS_BETA_CELLS+0.070
- BILE_ACID_METABOLISM+0.030
- ADIPOGENESIS+0.000
- HEME_METABOLISM-0.040
Top 10 suppressed
- E2F_TARGETS-0.580
- G2M_CHECKPOINT-0.550
- ALLOGRAFT_REJECTION-0.540
- MTORC1_SIGNALING-0.510
- TNFA_SIGNALING_VIA_NFKB-0.500
- INFLAMMATORY_RESPONSE-0.470
- COMPLEMENT-0.430
- IL6_JAK_STAT3_SIGNALING-0.390
- MYC_TARGETS_V2-0.390
- REACTIVE_OXYGEN_SPECIES_PATHWAY-0.390
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
10 twins match this tumor's tissue · 0 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | C3N-01409 | — | cohortA1 | 0.895 |
| 2 | MNG770 | — | — | 0.872 |
| 3 | TCGA-78-7161-01A-11R-2039-07 | — | cohortA3 | 0.872 |
| 4 | C3L-02165 | — | cohortA2 | 0.870 |
| 5 | SRR6013544 | — | cohortA1 | 0.863 |
| 6 | SRR8518225 | — | B | 0.861 |
| 7 | e3d71c3f-4e56-45fa-be88-2cf444b70a5c | — | — | 0.861 |
| 8 | TCGA-D8-A73X-01A-11R-A32P-07 | — | B | 0.855 |
| 9 | d69e622a-6dee-48f3-bf06-7f6148d7472a | — | — | 0.854 |
| 10 | C3N-03420 | — | cohortA1 | 0.852 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 8 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| UV_RESPONSE_DN | 0.190 | Inavolisib | — uncovered |
| ANGIOGENESIS | 0.140 | Remibrutinib | — uncovered |
| TGF_BETA_SIGNALING | 0.130 | Inavolisib | — uncovered |
| MYOGENESIS | 0.090 | Inavolisib | — uncovered |
| NOTCH_SIGNALING | 0.090 | Inavolisib | — uncovered |
| EPITHELIAL_MESENCHYMAL_TRANSITION | 0.080 | Inavolisib | — uncovered |
| PANCREAS_BETA_CELLS | 0.070 | Cobimetinib | — uncovered |
| BILE_ACID_METABOLISM | 0.030 | Inavolisib | — uncovered |